首页 > 市场调查报告书 > 医疗设备

导管药物递输设备

市场调查报告书

商品编码

1638727

製药和医疗塑胶配件和管材市场机会、成长动力、产业趋势分析和 2024 年至 2032 年预测

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年11月04日 | 出版商:

Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年，全球製药和医疗塑胶配件和管材市场价值为71.7亿美元，预计2024年至2032年复合年增长率为6.1%，主要是由一次性医疗设备需求不断增长推动的。对感染控制和交叉污染的日益担忧促使医疗保健提供者越来越多地采用一次性设备，例如静脉输液器、导管和药物输送系统。这些设备配备塑胶配件和管道，提供安全、无菌的解决方案，有助于降低患者风险。

生物製药的进步也加速了市场的成长，该产业更加重视生物製剂、疫苗和个人化治疗。这种转变增加了对无菌、无污染的流体处理系统的需求，其中塑胶配件和管道在确保药物製造和转移过程中的清洁和防止污染方面发挥着至关重要的作用。塑胶组件具有灵活性、耐化学性和一次性适用性，可支援不断扩大的生物製药生产，满足全球医疗保健需求，推动创新和市场扩张。

2023 年，管材领域引领市场，产生40.1 亿美元的收入，预计2024 年至2032 年将达到68.6 亿美元左右。具有灵活性、耐用性和客製化选项，使其成为医疗环境中可靠、无菌流体处理的理想选择。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	71.7 亿美元
预测值	121.3 亿美元
复合年增长率	6.1%

医院和诊所成为最大的最终用途领域，到2023 年占据36% 的市场份额，预计到2032 年将以6.4% 的复合年增长率增长。和药物管理和诊断，优先考虑无菌和感染控制。

在美国，用于製药和医疗应用的塑胶配件和管材市场到2023 年将超过24.5 亿美元，预计2024 年至2032 年复合年增长率为6.6%。和医疗机构网路。

产业生态系统分析
- 影响价值链的因素
- 利润率分析
- 干扰
- 未来展望
- 製造商
- 经销商
供应商格局
利润率分析
重要新闻和倡议
监管环境
衝击力
- 成长动力
  - 一次性医疗器材需求增加
  - 感染控制日益受到关注
  - 生物製药的进展
  - 严格的监管标准
- 产业陷阱与挑战
  - 环境问题
  - 污染风险
技术概览
原料分析
成长潜力分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：依产品类型，2021-2032 年

主要趋势
配件
- 连接器
- 适配器
- 阀门
- 鲁尔接头
- 快速连接配件
- 附刺配件
- 其他的
管道
- 单腔管
- 多腔管
- 波纹管
- 编织管
- 连续油管
- 其他的

第 6 章：市场估计与预测：按材料划分，2021-2032 年

主要趋势
聚氯乙烯 (PVC)
聚乙烯（PE）
聚丙烯（PP）
聚四氟乙烯
硅酮
热塑性弹性体 (TPE)
其他（尼龙、热塑性聚氨酯等）

第 7 章：市场估计与预测：依最终用途，2021-2032 年

主要趋势
医院和诊所
药品厂商
生技公司
研究实验室
医疗器材製造商

第 8 章：市场估计与预测：按配销通路，2021-2032

主要趋势
直接的
间接

第 9 章：市场估计与预测：按地区，2021-2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 英国
- 德国
- 法国
- 义大利
- 俄罗斯
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 印尼
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
MEA
- 南非
- 沙乌地阿拉伯
- 阿联酋

第 10 章：公司简介

AP Extrusion
Atlas Copco
Eldon James
Freudenberg Medical
Navtar
New Age Industries
Nordson
Parker Hannifin
Polymer Solutions
Qosina
Raumedic
Saint-Gobain Performance Plastics
Smiths Medical
Tekni-Plex
Trelleborg

简介目录

Product Code: 12086

The Global Plastic Fittings And Tubing For Pharmaceutical And Medical Market was valued at USD 7.17 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032, primarily driven by the rising demand for disposable medical devices. Rising concerns about infection control and cross-contamination are prompting healthcare providers to increasingly adopt single-use devices, such as IV sets, catheters, and drug delivery systems. These devices, equipped with plastic fittings and tubing, offer safe, sterile solutions that help reduce patient risks.

Biopharmaceutical advancements are also accelerating market growth, with the sector focusing more on biologics, vaccines, and personalized treatments. This shift has increased the need for sterile, contamination-free fluid handling systems, where plastic fittings and tubing play a vital role in ensuring cleanliness and preventing contamination during drug manufacturing and transfer. Offering flexibility, chemical resistance, and suitability for single-use, plastic components support the expanding biopharmaceutical production that meets global healthcare demands, driving innovation and market expansion.

In 2023, the tubing segment led the market, generating USD 4.01 billion in revenue and is expected to reach around USD 6.86 billion from 2024 to 2032. Plastic tubing is integral for fluid transfer in IV systems, drug delivery, and diagnostic equipment due to its flexibility, durability, and customization options, making it ideal for reliable, sterile fluid handling in medical environments.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$7.17 Billion
Forecast Value	$12.13 Billion
CAGR	6.1%

Hospitals and clinics emerged as the largest end-use segment, capturing a 36% market share in 2023 and anticipated to grow at a CAGR of 6.4% through 2032. These facilities rely heavily on disposable plastic parts for fluid management, IV therapy, drug administration, and diagnostics, prioritizing sterility and infection control.

In the U.S., the plastic fittings and tubing market for pharmaceuticals and medical applications surpassed USD 2.45 billion in 2023, with an estimated CAGR of 6.6% from 2024 to 2032. The advanced U.S. healthcare system, with its extensive network of hospitals, clinics, and specialized centers, drives significant demand for medical supplies, including plastic components essential for safe and efficient patient care.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Factor affecting the value chain
- 3.1.2 Profit margin analysis
- 3.1.3 Disruptions
- 3.1.4 Future outlook
- 3.1.5 Manufacturers
- 3.1.6 Distributors
3.2 Supplier landscape
3.3 Profit margin analysis
3.4 Key news & initiatives
3.5 Regulatory landscape
3.6 Impact forces
- 3.6.1 Growth drivers
  - 3.6.1.1 Increased demand for disposable medical devices
  - 3.6.1.2 Rising focus on infection control
  - 3.6.1.3 Advancements in biopharmaceuticals
  - 3.6.1.4 Stringent regulatory standards
- 3.6.2 Industry pitfalls & challenges
  - 3.6.2.1 Environmental concerns
  - 3.6.2.2 Risk of contamination
3.7 Technological overview
3.8 Raw Material analysis
3.9 Growth potential analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product Type, 2021-2032 (USD Billion) (Thousand Units)

5.1 Key trends
5.2 Fittings
- 5.2.1 Connectors
- 5.2.2 Adapters
- 5.2.3 Valves
- 5.2.4 Luer fittings
- 5.2.5 Quick-connect fittings
- 5.2.6 Barbed fittings
- 5.2.7 Others
5.3 Tubing
- 5.3.1 Single-lumen tubing
- 5.3.2 Multi-lumen tubing
- 5.3.3 Corrugated tubing
- 5.3.4 Braided tubing
- 5.3.5 Coiled tubing
- 5.3.6 Others

Chapter 6 Market Estimates & Forecast, By Materials, 2021-2032 (USD Billion) (Thousand Units)

6.1 Key trends
6.2 Polyvinyl Chloride (PVC)
6.3 Polyethylene (PE)
6.4 Polypropylene (PP)
6.5 PTFE
6.6 Silicone
6.7 Thermoplastic Elastomers (TPE)
6.8 Others (nylon, thermoplastic polyurethane, etc.)

Chapter 7 Market Estimates & Forecast, By End Use, 2021-2032 (USD Billion) (Thousand Units)

7.1 Key trends
7.2 Hospitals and clinics
7.3 Pharmaceutical manufacturers
7.4 Biotechnology companies
7.5 Research laboratories
7.6 Medical device manufacturers

Chapter 8 Market Estimates & Forecast, By Distribution Channel, 2021-2032 (USD Billion) (Thousand Units)

8.1 Key trends
8.2 Direct
8.3 Indirect

Chapter 9 Market Estimates & Forecast, By Region, 2021-2032 (USD Billion) (Thousand Units)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 UK
- 9.3.2 Germany
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Russia
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Indonesia
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE